Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Overweight × bupropion hydrochloride, naltrexone hydrochoride drug combination × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Overweight 1 Obesity 1 Breast Neoplasms 1

Interventions

Naltrexone 2 Exercise 2 Cognitive Behavioral Therapy 2 Bupropion 2 sultamicillin 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Psychology, Positive 1 Methods 1 Diet, Plant-Based 1 Diet, Mediterranean 1 Diet Therapy 1 Caloric Restriction 1 Blood Specimen Collection 1 Biopsy, Needle 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04499950 2025-03-06

A-NEW

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed

53 enrolled 14 charts

Breast Neoplasms, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡